TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

ANDOVER, Mass., Feb. 12, 2024 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks